Pomegranate Health Pricing: Month-to-Month Rates vs Long-Term Costs

Last reviewed: September 15, 2026 Last updated: September 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Pomegranate Health's product pages advertise $119/month for compounded semaglutide and $149/month for compounded tirzepatide plus B6, with no separate membership fee and monthly billing (joinpomegranate.com, captured September 4, 2026). Those advertised rates undercut PlexusDx's month-to-month semaglutide ($189) and tirzepatide ($289) by $70 and $140 per month respectively. Over 12 months at the advertised rates, Pomegranate Health's semaglutide totals $1,428 versus PlexusDx's $2,268 month-to-month, a difference of $840—our calculation. The tirzepatide gap is wider: $1,788 versus $3,468, a difference of $1,680—our calculation.

Two caveats limit confidence in those 12-month projections. First, Pomegranate Health's pricing documentation notes "dose tiers in app" for both medications, meaning the $119 and $149 figures may apply only to a starting tier; higher doses may cost more, but the full ladder is not published. Second, historical materials mention a consult deposit, though the current product page claims no membership or extra fee; we recommend confirming the total upfront and recurring charges at checkout. PlexusDx offers prepaid three-month and six-month plans ($169 and $149/month for semaglutide, $269 and $249/month for tirzepatide) that narrow or eliminate the gap where prepayment is feasible, and PlexusDx's pricing is flat at every dose—no tier increases as your prescription adjusts.

At-a-glance comparison: Pomegranate Health vs PlexusDx

All figures captured or calculated September 2026. 12-month totals are our calculation. Pomegranate Health figures from joinpomegranate.com (September 4, 2026); PlexusDx figures from plexusdx.com (July 2026).

Breaking down Pomegranate Health's advertised pricing

Pomegranate Health's compounded-semaglutide product page states $119/month with monthly billing and no membership or extra fee (captured September 4, 2026). The compounded-tirzepatide-plus-B6 page states $149/month, also monthly billing, also no membership fee (captured September 4, 2026). Both medications are described as injection formulations sourced from compounding pharmacies; neither is FDA-approved.

The pricing rows in our dataset note "dose tiers in app" for both medications, meaning the published $119 and $149 rates may represent a starting or lower-maintenance dose tier rather than a universal flat rate. Pomegranate Health's app or provider portal may display a tiered ladder; we did not observe the full ladder during our September 4 capture, so we cannot confirm whether stepping up from 0.25 mg to 1 mg semaglutide, or from 2.5 mg to 10 mg tirzepatide, triggers a higher monthly charge. The dataset instructs "verify full dose ladder in app," signaling that users should ask their Pomegranate Health provider or check the app's billing section before assuming the advertised rate will hold through dose escalation.

Our dataset also flags a checkout-confirmation caveat: the product page claims no membership or extra fee, but historical materials mention a consult deposit. We did not capture a checkout flow or invoice verifying zero upfront cost beyond the medication price. Confirm the total first-month charge—medication, consult, any deposit—before committing.

12-month cost math: Pomegranate Health vs PlexusDx

Semaglutide: $119 advertised month-to-month vs $189 or $149 flat

If Pomegranate Health's $119/month rate applies at every dose you use over 12 months, the annual total is $119 × 12 = $1,428—our calculation. PlexusDx's month-to-month semaglutide is $189/month, yielding $189 × 12 = $2,268—our calculation—a difference of $840 in Pomegranate Health's favor over one year.

PlexusDx offers a six-month prepaid plan at $149/month ($894 upfront, repeated twice for 12 months = $1,788—our calculation). That six-month rate is $30/month higher than Pomegranate Health's advertised rate, totaling $360 more over 12 months—our calculation—if Pomegranate Health's rate remains $119 at your prescribed dose. If Pomegranate Health's dose-tier pricing increases your cost to $150 or above at a higher dose, the PlexusDx six-month plan becomes competitive or cheaper on an annual basis, and you avoid mid-year price surprises because PlexusDx's rate is flat at every dose.

Tirzepatide: $149 advertised "starter" vs $289 or $249 flat

Pomegranate Health's tirzepatide page labels the $149 rate as "tirzepatide + B6 starter," suggesting this is an entry-tier price. At that rate for 12 months, the total is $149 × 12 = $1,788—our calculation. PlexusDx's month-to-month tirzepatide is $289/month, yielding $289 × 12 = $3,468—our calculation—a difference of $1,680 in Pomegranate Health's favor. Even PlexusDx's six-month prepaid rate ($249/month, $1,494 upfront twice = $2,988 annual—our calculation) is $100/month and $1,200/year higher than Pomegranate Health's advertised starter rate—our calculation.

The "starter" label and "dose tiers in app" note raise the same question: does the $149 rate hold at 7.5 mg or 10 mg tirzepatide, or does a higher tier apply? If your provider titrates you to a higher dose and the app reflects a higher monthly charge, the actual 12-month cost will exceed $1,788. We did not capture tier pricing above the starter level, so confirm your rate at each dose adjustment.

Decision factors: advertised low rate vs dose-tier uncertainty

Pomegranate Health's advertised-rate advantage

Where the $119 semaglutide or $149 tirzepatide rate applies, Pomegranate Health offers a materially lower monthly cost than PlexusDx's month-to-month option and a modest advantage over PlexusDx's six-month prepaid semaglutide rate. For a user who remains at a lower maintenance dose—never escalating beyond the tier the advertised rate covers—the 12-month savings are substantial: $840/year for semaglutide (versus PlexusDx month-to-month) or $1,680/year for tirzepatide (versus PlexusDx month-to-month)—our calculations. Monthly billing means no large upfront outlay and the flexibility to pause or cancel without forfeiting prepaid months.

Dose-tier risk and budgeting friction

The "dose tiers in app" flag introduces uncertainty into long-term cost projections. If your provider increases your dose and the app displays a higher monthly charge, your actual spend will exceed the advertised rate × 12. Without the full tier ladder, you cannot model the total cost of a typical titration schedule (e.g., semaglutide 0.25 mg → 0.5 mg → 1 mg over six months). That uncertainty complicates budgeting and makes it harder to compare Pomegranate Health's effective annual cost to a competitor's flat-rate plan. PlexusDx's pricing is flat at every dose: $189 month-to-month or $149 six-month prepaid for semaglutide, $289 month-to-month or $249 six-month prepaid for tirzepatide, regardless of whether you stay at 0.25 mg or climb to 2 mg. You know the 12-month cost on day one.

Checkout and consult-fee ambiguity

Pomegranate Health's product page states no membership or extra fee (captured September 4, 2026), but our dataset notes that historical materials mention a consult deposit and labels the evidence "primary-conflict," instructing users to confirm current checkout. We did not verify a zero-consult-fee checkout flow. Ask Pomegranate Health's intake or support team whether the first month includes a consult charge, a one-time deposit, or any other fee beyond the medication price. If a $50 or $100 consult fee applies, add that to your first-month cost when comparing total outlay.

Choose Pomegranate Health if…

• You prioritize the lowest possible advertised monthly rate and are willing to confirm at checkout and at each dose adjustment that the rate holds.
• You prefer month-to-month billing with no prepayment commitment, giving you flexibility to pause or switch providers without losing prepaid funds.
• Your provider anticipates you will remain at a lower maintenance dose long-term, reducing the risk that a dose-tier increase will erase the advertised-rate advantage.
• You are comfortable navigating an app-based platform to verify dose-tier pricing and any consult or service fees before each billing cycle.

Choose PlexusDx if…

• You want transparent, flat-at-every-dose pricing with no tier surprises as your prescription adjusts—$189 month-to-month or $149 six-month prepaid for semaglutide, $289 month-to-month or $249 six-month prepaid for tirzepatide.
• You value predictable 12-month budgeting: you know the annual cost on day one, whether you stay at 0.25 mg or escalate to 2 mg semaglutide or 10 mg tirzepatide.
• You are open to a prepaid multi-month plan to lower the per-month rate (six-month semaglutide at $149/month matches Pomegranate Health's advertised tirzepatide rate and sits $30/month above Pomegranate Health's advertised semaglutide rate, with no dose-tier risk).
• You want a provider with a verified Trustpilot rating: PlexusDx holds 4.3 stars with 79% five-star reviews and 83% four stars or higher (Trustpilot, captured September 9, 2026).
• You prefer no app-login requirement to verify pricing; PlexusDx publishes all rates and the flat-dose policy on public product pages.

Methodology and freshness

We captured Pomegranate Health's advertised pricing from joinpomegranate.com/products/compounded-semaglutide and app.joinpomegranate.com/pricing on September 4, 2026. PlexusDx pricing was captured from plexusdx.com product pages between July 17 and July 23, 2026, and verified against canonical rate cards through September 2026. The 12-month cost calculations ($1,428, $1,788, $2,268, $2,988, $3,468) and cost differences ($840, $1,680, $360, $1,200) are our calculations, derived by multiplying monthly rates by 12 or by summing prepaid-period costs over 12 months. We did not observe Pomegranate Health's full dose-tier ladder or complete a checkout flow; the article notes where verification is recommended. PlexusDx's Trustpilot rating (4.3 stars, 79% five-star, 83% four-star or higher) was captured September 9, 2026, from trustpilot.com/review/plexusdx.com. No promotional codes, first-month discounts, or limited-time offers are included; all figures represent standard or advertised ongoing rates as of the capture dates.

Frequently Asked Questions

Does Pomegranate Health charge the same $119 rate at every semaglutide dose?

Pomegranate Health's pricing documentation notes "dose tiers in app" for semaglutide, meaning the $119/month advertised rate may apply only to a starting or lower-tier dose. Higher doses may cost more, but the full tier ladder is not published on the public product page. Confirm your rate at each dose adjustment through the Pomegranate Health app or with your provider.

Is there a consult fee or deposit on top of the medication price?

Pomegranate Health's product page states no membership or extra fee (captured September 4, 2026), but historical materials mention a consult deposit. We did not verify a checkout flow. Ask Pomegranate Health's intake or support team whether any consult charge, deposit, or other fee applies to your first or recurring months before committing.

How does PlexusDx's six-month semaglutide rate compare to Pomegranate Health's advertised rate?

PlexusDx's six-month prepaid semaglutide plan is $149/month ($894 upfront, $1,788 over 12 months—our calculation). Pomegranate Health's advertised month-to-month semaglutide rate is $119/month ($1,428 over 12 months—our calculation), a difference of $360/year in Pomegranate Health's favor—our calculation—if the $119 rate holds at your dose. PlexusDx's rate is flat at every dose; Pomegranate Health's rate may increase with dose-tier escalation.

What is the 12-month cost difference for tirzepatide between the two providers?

Pomegranate Health's advertised tirzepatide starter rate is $149/month ($1,788/year—our calculation). PlexusDx's month-to-month tirzepatide is $289/month ($3,468/year—our calculation), a difference of $1,680 in Pomegranate Health's favor—our calculation. PlexusDx's six-month prepaid tirzepatide is $249/month ($2,988/year—our calculation), still $100/month and $1,200/year higher than Pomegranate Health's advertised starter rate—our calculation, assuming that rate applies at your dose.

Are Pomegranate Health's medications FDA-approved?

No. Pomegranate Health offers compounded semaglutide and compounded tirzepatide, neither of which is FDA-approved. Compounded medications are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Sources

• Pomegranate Health compounded-semaglutide product page, joinpomegranate.com/products/compounded-semaglutide, accessed September 4, 2026
• Pomegranate Health pricing page, app.joinpomegranate.com/pricing, accessed September 4, 2026
• PlexusDx semaglutide-injection product page, plexusdx.com/products/semaglutide-injection, accessed July 17–23, 2026
• PlexusDx tirzepatide-injection product page, plexusdx.com/products/tirzepatide-injection, accessed July 17–23, 2026
• PlexusDx Trustpilot profile, trustpilot.com/review/plexusdx.com, accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.